With over 45 years of expertise in strain improvement, the company serves global clients, including pharmaceutical and biotech leaders in North America, Europe, and Asia. Since its inception, Panlabs has successfully executed 300+ projects for 105 clients, offering services such as strain improvement, fermentation process development, product recovery, purification, semi-synthetic production, and
scale-up. In recent years, it actively innovates high-value generic and cancer drugs, achieving success in ADC drug research and application. Panlabs also houses a microbial library with 20,000+ strains, widely applicable across food, biotech, pharmaceuticals, environmental protection, and green industries. Beyond customized project services, Panlabs welcomes collaborative models with clients to jointly develop products and maximize value creation.‘
